Race Oncology Investor Relations Material
Latest events
AGM 2024
Race Oncology
Q3 2025 TU
22 Apr, 2025
H1 2025
24 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Race Oncology Limited
Access all reports
Race Oncology Limited is an Australian-based pharmaceutical company focused on the development and commercialization of oncology therapies. The company is dedicated to researching and advancing treatments for cancer, particularly through its drug discovery and development programs. Race Oncology employs precision medicine approaches and targets specific cancer-related pathways to address unmet needs in cancer care. The company is headquartered in Sydney, Australia, and its shares are listed on the ASX.
Key slides for Race Oncology Limited
Investor Presentation
Race Oncology Limited
Investor Presentation
Race Oncology Limited
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
RAC
Country
🇦🇺 Australia